BMO Capital Maintains Outperform on Aveanna Healthcare Hldgs, Raises Price Target to $14

BMO Capital analyst Sean Dodge maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform and raises the price target from $10 to $14.